本页面由Tiger Trade Technology Pte. Ltd.提供服务

Esperion Therapeutics Inc.

3.69
+0.520016.40%
盘后3.67-0.0200-0.54%16:25 EST
成交量:1,914.63万
成交额:6,940.16万
市值:8.82亿
市盈率:-6.89
高:3.77
开:3.28
低:3.28
收:3.17
52周最高:3.94
52周最低:0.6925
股本:2.39亿
流通股本:2.37亿
量比:2.93
换手率:8.08%
股息:- -
股息率:- -
每股收益(TTM):-0.5358
每股收益(LYR):-0.2764
净资产收益率:97.76%
总资产收益率:-5.42%
市净率:-1.95
市盈率(LYR):-13.35

数据加载中...

2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

重要事件披露

Form 8-K - Current report
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/17

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/08/05

重要事件披露

Form 8-K - Current report
2024/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities